Lyme Disease and Persistent Antibodies After Treatment
A previous Lyme disease infection treated with antibiotics five years ago is highly likely to cause a positive result on routine serologic blood tests, but this represents persistent antibodies from past infection rather than a "false positive."
Understanding Post-Treatment Seropositivity
The key distinction here is that this is not technically a false positive—it's a true positive for antibodies that persist after successful treatment. According to established guidelines, antibodies to Borrelia burgdorferi often persist for months or years after successfully treated or untreated infection 1. This is a well-documented phenomenon that clinicians must understand to avoid misinterpreting test results.
What the Evidence Shows
- IgG antibodies are remarkably persistent: Research demonstrates that of patients whose initial serum was positive for IgG antibody, 19 of 23 (83%) remained positive at follow-up a mean of 16 months after treatment 2
- IgG immunoblot bands remain constant: The banding patterns on Western blot stay remarkably stable over time after treatment 2
- Seroreactivity alone cannot indicate active disease: Guidelines explicitly state that positive serologic results or a history of previous Lyme disease does not ensure protective immunity, nor does it indicate current active infection 1
Clinical Implications
Critical Pitfall to Avoid
The most important caveat: Do not interpret persistent positive serology as evidence of active infection or treatment failure. This misinterpretation leads to:
- Unnecessary repeat antibiotic courses
- Misdiagnosis of new symptoms as "chronic Lyme disease"
- Inappropriate testing in patients with unrelated conditions
When Positive Tests Matter (and When They Don't)
After 4 weeks of symptoms, IgM testing becomes unreliable and has a high likelihood of false-positive results for current infection 3. In your scenario (5 years post-treatment):
- IgM positive results should be disregarded as they likely represent false positives
- IgG positive results are expected and represent immunologic memory, not active disease
- Clinical context is paramount: Diagnosis requires compatible clinical findings and epidemiologic exposure, not serology alone 1, 4
Practical Guidance
If Testing Was Ordered
- Determine what type of test was performed: Was it screening ELISA/EIA, or was Western blot performed?
- Check which antibody class is positive: IgM or IgG?
- Assess clinical context: Are there objective signs of Lyme disease (erythema migrans, neurologic findings, arthritis, cardiac manifestations)?
The Bottom Line
In a patient with treated Lyme disease from 5 years ago who has a positive serologic test on routine screening:
- This represents persistent antibodies from past infection (especially if IgG positive)
- No treatment is indicated based on serology alone
- Clinical diagnosis requires objective findings compatible with Lyme disease, not just positive serology 1, 4
- Consider that false-positive IgM results occur in 27.5% of clinical practice cases and lead to unnecessary antibiotic use in 78% of those patients 5
When to Actually Worry
Only pursue further evaluation if the patient has:
- New objective clinical manifestations (erythema migrans >5cm, neurologic findings like meningitis or cranial neuropathies, documented arthritis, cardiac conduction abnormalities)
- Recent epidemiologically plausible tick exposure in an endemic area
- Symptoms that fit established Lyme disease syndromes 4
Routine screening in asymptomatic individuals or those with nonspecific symptoms leads to more false positives than true positives and should be avoided 6.